Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases · Source last updated 2025-02-10
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
MEAN
Unit
Mean % radiation dose to % organ volume
Interval / dispersion
Standard Deviation
Time frame
This outcome is measured from central review of radiation plans within 1-2 days of receipt.
What was measured
The IMRT and standard anteroposterior (AP-PA) treatment plans were reviewed and compared for target coverage and organ dose-volume histograms. The mean percentage volume of the organ or organ sub-region receiving a percentage of the dose was estimated from the computerized treatment plans for these two techniques were estimated and compared statistically
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Treatment (IMRT)
20
Reported measurements
Heart - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
96
5.4
Not reported
Not reported
Not reported
Heart - V50 (%) for AP- PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
0.8
Not reported
Not reported
Not reported
Heart - V83 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
65
12.1
Not reported
Not reported
Not reported
Heart - V83 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
2.2
Not reported
Not reported
Not reported
Heart - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
39
15.5
Not reported
Not reported
Not reported
Heart- V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
97
6.7
Not reported
Not reported
Not reported
Left Ventricle - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
95
7.8
Not reported
Not reported
Not reported
Left Ventricle - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
0
Not reported
Not reported
Not reported
Left Ventricle - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
33
15.9
Not reported
Not reported
Not reported
Left Ventricle - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
2.7
Not reported
Not reported
Not reported
Right Ventricle - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
91
9.8
Not reported
Not reported
Not reported
Right Ventricle - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
1.6
Not reported
Not reported
Not reported
Right Ventricle - V83 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
42
12.7
Not reported
Not reported
Not reported
Right Ventricle - V83 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
4
Not reported
Not reported
Not reported
Right Ventricle - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
18
8.9
Not reported
Not reported
Not reported
Right Ventricle - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
97
8.2
Not reported
Not reported
Not reported
Right Atrium - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
0.4
Not reported
Not reported
Not reported
Right Atrium - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
0.7
Not reported
Not reported
Not reported
Right Atrium - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
57
22.5
Not reported
Not reported
Not reported
Right Atrium - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
97
11.1
Not reported
Not reported
Not reported
Left Atrium V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
0.4
Not reported
Not reported
Not reported
Left Atrium V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
0.2
Not reported
Not reported
Not reported
Left Atrium - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
55
22.3
Not reported
Not reported
Not reported
Left Atrium - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
94
15.4
Not reported
Not reported
Not reported
Right Coronary Artery - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
0
Not reported
Not reported
Not reported
Right Coronary Artery - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
0
Not reported
Not reported
Not reported
Left Coronary Artery - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
88
9.9
Not reported
Not reported
Not reported
Left Coronary Artery - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
1.3
Not reported
Not reported
Not reported
Myocardium - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
94
8
Not reported
Not reported
Not reported
Myocardium - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
100
0
Not reported
Not reported
Not reported
Myocardium - V95 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
69
7.56
Not reported
Not reported
Not reported
Myocardium - V95 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
99
0.88
Not reported
Not reported
Not reported
Thyroid - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
44
32.5
Not reported
Not reported
Not reported
Thyroid - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
33
31.3
Not reported
Not reported
Not reported
Kidneys - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
5
7.6
Not reported
Not reported
Not reported
Kidneys - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
6
6.8
Not reported
Not reported
Not reported
Stomach - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
62
21.7
Not reported
Not reported
Not reported
Stomach - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
62
24.5
Not reported
Not reported
Not reported
Liver - V50 (%) for IMRT
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
55
11.4
Not reported
Not reported
Not reported
Liver - V50 (%) for AP-PA
Values in Mean % radiation dose to % organ volume · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Treatment (IMRT)
54
11.4
Not reported
Not reported
Not reported
Source statistical analyses
Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.
group Description
Feasibility will be defined as an enrolled patient receiving the IMRT treatment as planned. It is expected that the treatment will be feasible in at least 90% of patients. If the treatment is feasible in 16 or more out of 20 patients, then the treatment will be declared feasible. If the true feasibility rate is 90%, then there is a 4.3% chance that 15 or fewer feasible patients will be observed.
group Ids
OG000
non Inferiority Comment
With 20 patients, there is 80% power to detect a difference of 100% with Standard lung RT versus 93% with IMRT assuming a standard deviation of 8 (as seen for the whole heart), a one tailed test and a Bonferroni correction for 4 statistical tests so that each test is done at p\<0.0125.
non Inferiority Type
OTHER
other Analysis Description
Lung-metastases-free survival will be estimated using Kaplan-Meier survival curves (minimum period of six months).
p Value
<0.0125
p Value Comment
The reported p value was calculated. The statistical analysis performed is attached to the outcome measure reported.
statistical Method
Bonferroni corrected at p<0.0125
Complete source fields
analyses
group Description
Feasibility will be defined as an enrolled patient receiving the IMRT treatment as planned. It is expected that the treatment will be feasible in at least 90% of patients. If the treatment is feasible in 16 or more out of 20 patients, then the treatment will be declared feasible. If the true feasibility rate is 90%, then there is a 4.3% chance that 15 or fewer feasible patients will be observed.
group Ids
OG000
non Inferiority Comment
With 20 patients, there is 80% power to detect a difference of 100% with Standard lung RT versus 93% with IMRT assuming a standard deviation of 8 (as seen for the whole heart), a one tailed test and a Bonferroni correction for 4 statistical tests so that each test is done at p\<0.0125.
non Inferiority Type
OTHER
other Analysis Description
Lung-metastases-free survival will be estimated using Kaplan-Meier survival curves (minimum period of six months).
p Value
<0.0125
p Value Comment
The reported p value was calculated. The statistical analysis performed is attached to the outcome measure reported.
statistical Method
Bonferroni corrected at p<0.0125
classes
categories
measurements
group Id
OG000
spread
5.4
value
96
title
Heart - V50 (%) for IMRT
categories
measurements
group Id
OG000
spread
0.8
value
100
title
Heart - V50 (%) for AP- PA
categories
measurements
group Id
OG000
spread
12.1
value
65
title
Heart - V83 (%) for IMRT
categories
measurements
group Id
OG000
spread
2.2
value
100
title
Heart - V83 (%) for AP-PA
categories
measurements
group Id
OG000
spread
15.5
value
39
title
Heart - V95 (%) for IMRT
categories
measurements
group Id
OG000
spread
6.7
value
97
title
Heart- V95 (%) for AP-PA
categories
measurements
group Id
OG000
spread
7.8
value
95
title
Left Ventricle - V50 (%) for IMRT
categories
measurements
group Id
OG000
spread
0
value
100
title
Left Ventricle - V50 (%) for AP-PA
categories
measurements
group Id
OG000
spread
15.9
value
33
title
Left Ventricle - V95 (%) for IMRT
categories
measurements
group Id
OG000
spread
2.7
value
99
title
Left Ventricle - V95 (%) for AP-PA
categories
measurements
group Id
OG000
spread
9.8
value
91
title
Right Ventricle - V50 (%) for IMRT
categories
measurements
group Id
OG000
spread
1.6
value
100
title
Right Ventricle - V50 (%) for AP-PA
denoms
counts
group Id
OG000
value
20
units
Participants
description
The IMRT and standard anteroposterior (AP-PA) treatment plans were reviewed and compared for target coverage and organ dose-volume histograms. The mean percentage volume of the organ or organ sub-region receiving a percentage of the dose was estimated from the computerized treatment plans for these two techniques were estimated and compared statistically